1-2 of 2
Naveed Sarwar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

Simon J. Crabb, Sarah Danson, James W.F. Catto, Syed Hussain, Danna Chan, Denise Dunkley, Nichola Downs, Ellice Marwood, Laura Day, Geoff Saunders, Michelle Light, Amy Whitehead, Deborah Ellis, Naveed Sarwar, Deborah Enting, Alison Birtle, Bernadette Johnson, Robert Huddart, Gareth Griffiths
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (7): 1882–1892.
https://doi.org/10.1158/1078-0432.CCR-20-3946
Published: 01 April 2021
View article titled, Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)
Open the PDF for Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE) in another window
Includes: Supplementary data
Journal Articles

Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients

Jie Jiang, Naveed Sarwar, David Peston, Elena Kulinskaya, Sami Shousha, R. Charles Coombes, Simak Ali
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5769–5776.
https://doi.org/10.1158/1078-0432.CCR-07-0822
Published: 01 October 2007
View article titled, Phosphorylation of Estrogen Receptor-α at Ser<sup>167</sup> Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients
Open the PDF for Phosphorylation of Estrogen Receptor-α at Ser<sup>167</sup> Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients in another window